PB1947: A META-ANALYTIC ENDPOINT VALIDATION OF SURROGATES USED IN CLINICAL TRIALS EVALUATING THE EFFICACY OF THERAPIES IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

• Nasim Bahar,
• Leyla Mohseninejad,
• Keltie Mcdonald,
• Thomas Wilke

Affiliations

Nasim Bahar

1 BeiGene Switzerland GmbH, HEOR (Global and Europe), Basel, Switzerland

Leyla Mohseninejad

1 BeiGene Switzerland GmbH, HEOR (Global and Europe), Basel, Switzerland

Keltie Mcdonald

2 Cytel Inc, Waltham, United States

Thomas Wilke

3 Affiliated institute of the University of Wismar, Institut für Pharmakoökonomie und Arzneimittellogistik, Germany